190 related articles for article (PubMed ID: 1393276)
21. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
22. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
23. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine.
Podzuweit T; Nennstiel P; Müller A
Cell Signal; 1995 Sep; 7(7):733-8. PubMed ID: 8519602
[TBL] [Abstract][Full Text] [Related]
24. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle.
Weishaar RE; Kobylarz-Singer DC; Kaplan HR
J Mol Cell Cardiol; 1987 Oct; 19(10):1025-36. PubMed ID: 2830402
[TBL] [Abstract][Full Text] [Related]
25. Localization of low-KM cAMP phosphodiesterase in rat nephron segments.
Yoshida I; Takeda S; Homma S; Kusano E; Asano Y
Kidney Blood Press Res; 1997; 20(5):307-11. PubMed ID: 9419046
[TBL] [Abstract][Full Text] [Related]
26. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
27. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
[TBL] [Abstract][Full Text] [Related]
28. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Ellis JL; Conanan ND
J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.
Stief CG; Taher A; Truss M; Becker AJ; Schulz-Knappe P; Meyer M; Uckert S; Forssmann WG; Jonas U
Urol Int; 1995; 55(4):183-9. PubMed ID: 8588263
[TBL] [Abstract][Full Text] [Related]
30. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
Rabe KF; Tenor H; Dent G; Schudt C; Nakashima M; Magnussen H
Am J Physiol; 1994 May; 266(5 Pt 1):L536-43. PubMed ID: 7515580
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase IV inhibitors synergistically potentiate relaxation induced by forskolin in guinea-pig trachea.
Tanizawa M; Watanabe T; Kume H; Yamaki K; Miyamoto K; Takagi K
Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):114-9. PubMed ID: 9493499
[TBL] [Abstract][Full Text] [Related]
32. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity.
Elliott KR; Berry JL; Bate AJ; Foster RW; Small RC
J Enzyme Inhib; 1991; 4(3):245-51. PubMed ID: 1645399
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
Sawanishi H; Suzuki H; Yamamoto S; Waki Y; Kasugai S; Ohya K; Suzuki N; Miyamoto K; Takagi K
J Med Chem; 1997 Sep; 40(20):3248-53. PubMed ID: 9379444
[TBL] [Abstract][Full Text] [Related]
34. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle.
Taher A; Meyer M; Stief CG; Jonas U; Forssmann WG
World J Urol; 1997; 15(1):32-5. PubMed ID: 9066092
[TBL] [Abstract][Full Text] [Related]
35. Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum.
Mukai J; Asai T; Naka M; Tanaka T
Br J Pharmacol; 1994 Feb; 111(2):389-90. PubMed ID: 8004382
[TBL] [Abstract][Full Text] [Related]
36. Cyclic nucleotide phosphodiesterase isoenzymes and asthma--outstanding issues.
Nicholson CD
Agents Actions Suppl; 1993; 43():3-12. PubMed ID: 8396317
[TBL] [Abstract][Full Text] [Related]
37. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
Schudt C; Winder S; Eltze M; Kilian U; Beume R
Agents Actions Suppl; 1991; 34():379-402. PubMed ID: 1665311
[TBL] [Abstract][Full Text] [Related]
38. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
39. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
40. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
Reeves ML; Leigh BK; England PJ
Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
